Internship - Acoustic metamaterials and active noise control
Ora
Summary
We are seeking graduate students interested in advancing acoustic metamaterials and active noise control technologies for reducing machine noise and improving acoustic privacy. The interns will collaborate with MERL researchers to develop novel approaches for controlling sound propagation through a combination of passive acoustic structures and active sound field control.
Job description
Research Areas
- Design and optimization of acoustic metamaterials
- Microphone and loudspeaker array processing
- Adaptive noise cancellation
- Experimental validation of noise reduction and speech privacy systems
Responsibilities
- Develop and implement algorithms
- Conduct acoustic simulations and measurements
- Build experimental prototypes
- Prepare results for publication
Flexible start dates and internship durations (typically 3–6 months) are available.
Requirements
- Ph.D. student
- Experience in acoustics, acoustic metamaterials, active noise control, adaptive filtering, acoustic wave propagation, microphone and loudspeaker arrays, numerical simulation, or signal processing
- Experience with finite element modeling, optimization, or physics-informed machine learning is desirable
- Full authorization to work in the U.S.
Benefits
- Relocation Stipend
- Covered Travel To And From MERL
- Monthly Charlie Card
- Health Insurance
- Professional Development Opportunities
Company overview
Ora is the world's leading full-service ophthalmic drug and device development firm, operating as a specialized contract research organization (CRO) focused exclusively on ophthalmology. Founded in 1974 and headquartered in Andover, Massachusetts, the company has over 45 years of experience in advancing eye care innovations globally. Ora provides comprehensive research and development services spanning preclinical studies, clinical trials, regulatory strategy, and product development for both pharmaceutical and medical device companies. With operations across the United States, United Kingdom, Australia, and Asia, the company has helped clients achieve more than 85 product approvals to date. Ora's expertise covers a wide range of ophthalmic conditions including allergy, dry eye, retina diseases, glaucoma, and anti-infective therapies. The company employs over 500 ophthalmology specialists who utilize proprietary clinical models, integrated data solutions, and global regulatory strategies to accelerate product development from concept to market. Ora serves a diverse client base ranging from startups to global pharmaceutical and device companies, positioning itself as the trusted partner for ophthalmic innovation worldwide.